Nina Tandon

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignees: Avaya Inc., Columbia University. Active years: 2013-2019.

USPTO Granted Patents = 5 (Patent Applications = 1)

% Patents Active = 60.0

Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 20(Granted Patents)

Company Filing History:

Years Active: 2013-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10488390 - System and method for high-throughput assessment of cellular cardiotoxicity, drug screening, and cardiogenic factors via online physiological measurements (2019-11-26),

2. 9206383 - Bioreactor, devices, systems and methods (2015-12-08),

3. 9124643 - Method and apparatus for a publish-subscribe system with templates for role-based view of subscriptions (2015-09-01),

4. 8566311 - Method and apparatus for notifying a user of a predefined changes to dynamic attributes (2013-10-22),

5. 8495163 - Method and apparatus for a publish-subscribe system with templates for role-based view of subscriptions (2013-07-23),

Title: Nina Tandon: Innovator in Bioreactor Technology

Introduction

Nina Tandon is a prominent inventor based in New York, NY (US). She has made significant contributions to the field of bioreactor technology and cellular assessment. With a total of 5 patents to her name, Tandon is recognized for her innovative approaches to drug screening and cardiotoxicity assessment.

Latest Patents

Tandon's latest patents include a system and method for high-throughput assessment of cellular cardiotoxicity, drug screening, and cardiogenic factors via online physiological measurements. This integrated system is designed to detect safety and efficacy issues related to potential drug compounds by combining tissue maturation, imaging, and electrophysiology measurements at high throughput, ensuring a high signal-to-noise ratio. Another notable patent involves bioreactor devices, systems, and methods, which disclose a bioreactor system that includes one or more individually controllable and identifiable bioreactor modules. These modules can connect to various functional modules, allowing for comprehensive monitoring and control of the bioreactor system.

Career Highlights

Throughout her career, Nina Tandon has worked with notable organizations such as Avaya Inc. and Columbia University. Her experience in these institutions has contributed to her expertise in bioreactor technology and cellular assessment.

Collaborations

Tandon has collaborated with several professionals in her field, including Joann J Ordille and Qian Yang. These collaborations have further enhanced her research and development efforts in bioreactor systems.

Conclusion

Nina Tandon is a trailblazer in the field of bioreactor technology, with a focus on improving drug screening and safety assessments. Her innovative patents and career achievements highlight her significant impact on the industry.